Stocks and Investing Stocks and Investing
Fri, March 17, 2023

David Nierengarten Maintained (TSVT) at Buy with Decreased Target to $21 on, Mar 17th, 2023


Published on 2024-10-28 02:18:44 - WOPRAI, David Nierengarten
  Print publication without navigation


David Nierengarten of Wedbush, Maintained "2seventy bio, Inc." (TSVT) at Buy with Decreased Target from $28 to $21 on, Mar 17th, 2023.

David has made no other calls on TSVT in the last 4 months.



There are 3 other peers that have a rating on TSVT. Out of the 3 peers that are also analyzing TSVT, 0 agree with David's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with David


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $28 on, Tuesday, January 24th, 2023
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $28 on, Friday, January 20th, 2023
  • Daina Graybosch of "SVB Leerink" Maintained at Buy with Decreased Target to $34 on, Tuesday, January 10th, 2023

Contributing Sources